Enrique Grande, Head of Oncology at MD Anderson Cancer Center, shared a post on LinkedIn about a recent paper by Joyce Hwang et al. published in JCI Insight:

“Study identifies circulating immune biomarkers linked to response in metastatic renal cell carcinoma patients undergoing immunotherapy.

Elevated baseline levels of certain cytokines correlate with improved outcomes.
Findings may guide personalized treatment strategies.”

“Circulating immune biomarkers correlating with response in patients with metastatic renal cell carcinoma on immunotherapy”

Authors: Joyce Hwang et al.

Enrique Grande: Circulating immune biomarkers linked to response in mRCC patients undergoing immunotherapy

More posts featuring Enrique Grande.